{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T15:27:26Z","timestamp":1782487646506,"version":"3.54.5"},"reference-count":184,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centre for Strategic Planning and Management of Biomedical Health Risks"},{"name":"ANO","award":["1309-4\/25"],"award-info":[{"award-number":["1309-4\/25"]}]},{"DOI":"10.13039\/501100012190","name":"Ministry of Science and Higher Education of the Russian Federation","doi-asserted-by":"crossref","award":["FGFG-2025-0015"],"award-info":[{"award-number":["FGFG-2025-0015"]}],"id":[{"id":"10.13039\/501100012190","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Type 1 Diabetes Mellitus (T1D) is an autoimmune disease characterized by the destruction of pancreatic \u03b2-cells, predominantly manifesting in childhood or adolescence. The lack of clearly interpretable biological markers in the early stages, combined with the insidious onset of the disease, poses significant challenges to early diagnosis and the implementation of preventive strategies. The applicability of classic T1D biomarkers for understanding the mechanisms of the autoimmune process, preclinical diagnostics and treatment efficiency is limited. Despite advances in next-generation sequencing (NGS) technologies, which have enabled large-scale genome-wide association studies (GWASs) and the identification of polygenic risk scores (PRSs) associated with T1D predisposition, as well as progress in bioinformatics approaches for assessing dysregulated gene expression, no universally accepted risk assessment model or definitive predictive biomarker has been established. Until now, the use of new promising biomarkers for T1D diagnostics is limited by insufficient evidence base. However, they have great potential for the development of diagnostic methods on their basis, which has been shown in single or serial large-scale studies. This critical review covers both well-known biomarkers widely used in clinical practice, such as HLA-haplotype, non-HLA SNPs, islet antigen autoantibodies, C-peptide, and the promising ones, such as cytokines, cfDNA, microRNA, T1D-specific immune cells, islet-TCR, and T1D-specific vibrational bands. Additionally, we highlight new approaches that have been gaining popularity and have already demonstrated their potential: GWAS, single-cell transcriptomics, identification of antigen-specific T cells using scRNA-seq, and FTIR spectroscopy. Although some of the biomarkers, in our opinion, are still limited to a research context or are far from being implemented in clinical diagnostics of T1D, they have the greatest potential of being applied in clinical practice. When integrated with the monitoring of the classical autoimmune diabetes markers, they would increase the sensitivity and specificity during diagnostics of early and preclinical stages of the disease. This critical review aims to evaluate the current landscape of classical and emerging biomarkers in autoimmune diabetes, with a focus on those enabling early detection\u2014prior to extensive destruction of pancreatic islets. Another goal of the review is to focus the attention of the scientific community on the gaps in early T1D diagnostics, and to help in the selection of markers, targets, and methods for scientific studies on creating novel diagnostic panels.<\/jats:p>","DOI":"10.3390\/biomedicines13102444","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:48:30Z","timestamp":1759852110000},"page":"2444","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preclinical Diagnosis of Type 1 Diabetes: Reality or Utopia"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4310-7118","authenticated-orcid":false,"given":"Tatyana A.","family":"Marakhovskaya","sequence":"first","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1509-2206","authenticated-orcid":false,"given":"Dmitry V.","family":"Tabakov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0257-6439","authenticated-orcid":false,"given":"Olga V.","family":"Glushkova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"},{"name":"Institute of Cell Biophysics, Russian Academy of Sciences, PSCBR RAS, Institutskaya Street 3, 142290 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2982-2123","authenticated-orcid":false,"given":"Zoya G.","family":"Antysheva","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslava S.","family":"Kiseleva","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6680-6515","authenticated-orcid":false,"given":"Ekaterina S.","family":"Petriaikina","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0647-5421","authenticated-orcid":false,"given":"Nickolay A.","family":"Bugaev-Makarovskiy","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-5472","authenticated-orcid":false,"given":"Anna S.","family":"Tashchilova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0380-8144","authenticated-orcid":false,"given":"Vasiliy E.","family":"Akimov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia A.","family":"Krupinova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"},{"name":"Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 111123 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6377-9056","authenticated-orcid":false,"given":"Viktor P.","family":"Bogdanov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana M.","family":"Frolova","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6204-166X","authenticated-orcid":false,"given":"Victoria S.","family":"Shchekina","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"},{"name":"Bashliaeva Children\u2019s Municipal Clinical Hospital, Moscow City Health Department, Geroev Panfilovtsev Street 4, 125373 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina S.","family":"Avsievich","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"},{"name":"Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 111123 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerii V.","family":"Gorev","sequence":"additional","affiliation":[{"name":"Morozovskaya Children\u2019s City Clinical Hospital, 4 Dobryninskiy Pereulok, 1\/9, 119049 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina G.","family":"Rybkina","sequence":"additional","affiliation":[{"name":"Morozovskaya Children\u2019s City Clinical Hospital, 4 Dobryninskiy Pereulok, 1\/9, 119049 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismail M.","family":"Osmanov","sequence":"additional","affiliation":[{"name":"Bashliaeva Children\u2019s Municipal Clinical Hospital, Moscow City Health Department, Geroev Panfilovtsev Street 4, 125373 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina G.","family":"Kolomina","sequence":"additional","affiliation":[{"name":"Bashliaeva Children\u2019s Municipal Clinical Hospital, Moscow City Health Department, Geroev Panfilovtsev Street 4, 125373 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor E.","family":"Khatkov","sequence":"additional","affiliation":[{"name":"Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 111123 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia A.","family":"Bodunova","sequence":"additional","affiliation":[{"name":"Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 111123 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9199-6258","authenticated-orcid":false,"given":"Vladimir S.","family":"Yudin","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton A.","family":"Keskinov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7942-8004","authenticated-orcid":false,"given":"Sergey M.","family":"Yudin","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel Y.","family":"Volchkov","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Scientific Institution \u201cFederal Research Center for Innovator and Emerging Biomedical and Pharmaceutical Technologies\u201d, 125315 Moscow, Russia"},{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"},{"name":"Moscow Clinical Scientific Center N.A. A.S. Loginov, Novogireevskaya Street, 111123 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3776-9871","authenticated-orcid":false,"given":"Dmitry V.","family":"Svetlichnyy","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution \u00abCentre for Strategic Planning and Management of Biomedical Health Risks\u00bb of the Federal Medical and Biological Agency (Centre for Strategic Planning of the Federal Medical and Biological Agency), 119121 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Woroncow","sequence":"additional","affiliation":[{"name":"Moscow Center for Advanced Studies, Kulakova Street 20, 123592 Moscow, Russia"},{"name":"Faculty of Fundamental Medicine, Lomonosov Moscow State University, Leninskie Gory Street 1, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika I.","family":"Skvortsova","sequence":"additional","affiliation":[{"name":"The Federal Medical Biological Agency (FMBA of Russia), 117513 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: A modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00125-022-05778-3","article-title":"Precision medicine in type 1 diabetes","volume":"67","author":"Carr","year":"2022","journal-title":"Diabetologia"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Ma\u02d8nescu, M., Ma\u02d8nescu, I.B., and Grama, A. (2024). A review of stage 0 biomarkers in type 1 diabetes: The holy grail of early detection and prevention?. J. Pers. Med., 14.","DOI":"10.3390\/jpm14080878"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/pedi.13410","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Stages of type 1 diabetes in children and adolescents","volume":"23","author":"Besser","year":"2022","journal-title":"Pediatr. Diabetes"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2337\/dc21-1251","article-title":"Heterogeneity of type 1 diabetes at diagnosis supports existence of age-related endotypes","volume":"45","author":"Parviainen","year":"2022","journal-title":"Diabetes Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e120877","DOI":"10.1172\/jci.insight.120877","article-title":"\u03b2 Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis","volume":"3","author":"Sims","year":"2018","journal-title":"JCI Insight"},{"key":"ref_7","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody\u2013positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajhg.2022.12.011","article-title":"15 years of GWAS discovery: Realizing the promise","volume":"110","author":"Abdellaoui","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1007\/s00125-020-05115-6","article-title":"Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis","volume":"63","author":"Leete","year":"2020","journal-title":"Diabetologia"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e3770","DOI":"10.1002\/dmrr.3770","article-title":"Type 1 diabetes: A new vision of the disease based on endotypes","volume":"40","author":"Weston","year":"2024","journal-title":"Diabetes\/Metab. Res. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e15155","DOI":"10.1111\/dme.15155","article-title":"Differential expression of genes controlling lymphocyte differentiation and migration in two distinct endotypes of type 1 diabetes","volume":"40","author":"Torabi","year":"2023","journal-title":"Diabet. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s001250051626","article-title":"Heterogeneity of type I diabetes: Analysis of monozygotic twins in Great Britain and the United States","volume":"44","author":"Redondo","year":"2001","journal-title":"Diabetologia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11892-011-0223-x","article-title":"Genetics of the HLA region in the prediction of type 1 diabetes","volume":"11","author":"Noble","year":"2011","journal-title":"Curr. Diabetes Rep."},{"key":"ref_14","first-page":"75","article-title":"Immunogenetics of type 1 diabetes mellitus\u2014From fundamental ideas to medical practice","volume":"67","author":"Alekseev","year":"2012","journal-title":"Ann. Russ. Acad. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI78142","article-title":"\u03b2 cell death and dysfunction during type 1 diabetes development in at-risk individuals","volume":"125","author":"Herold","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jaut.2005.09.002","article-title":"Genetic prediction of autoimmunity: Initial oligogenic prediction of anti-islet autoimmunity amongst DR3\/DR4\u2013DQ8 relatives of patients with type 1A diabetes","volume":"25","author":"Aly","year":"2005","journal-title":"J. Autoimmun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: Emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nri1805","article-title":"MHC class II proteins and disease: A structural perspective","volume":"6","author":"Jones","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1111\/iji.12216","article-title":"HLA class II susceptibility pattern for type 1 diabetes (T1D) in an Iranian population","volume":"42","author":"Kiani","year":"2015","journal-title":"Int. J. Immunogenet."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Robino, A., Bevilacqua, E., Aldegheri, L., Conti, A., Bazzo, V., Tornese, G., and Catamo, E. (2024). Next-generation sequencing reveals additional HLA class I and class II alleles associated with type 1 diabetes and age at onset. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1427349"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db09-0680","article-title":"HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: Analysis of the type 1 diabetes genetics consortium families","volume":"59","author":"Varney","year":"2010","journal-title":"Diabetes"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1093\/hmg\/ddae024","article-title":"A multi-ancestry genome-wide association study in type 1 diabetes","volume":"33","author":"Michalek","year":"2024","journal-title":"Hum. Mol. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.2337\/db23-0387","article-title":"Increased Frequency of the HLA-DRB1* 04: 04-DQA1* 03-DQB1* 03: 02 Haplotype Among HLA-DQB1* 06: 02\u2013Positive Children With Type 1 Diabetes","volume":"73","author":"Ilonen","year":"2024","journal-title":"Diabetes"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-5448.2011.00833.x","article-title":"HLA-class II and class I genotypes among Japanese children with Type 1A diabetes and their families","volume":"13","author":"Sugihara","year":"2012","journal-title":"Pediatr. Diabetes"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/dme.12148","article-title":"HLA class II gene associations in African American Type 1 diabetes reveal a protective HLA-DRB1* 03 haplotype","volume":"30","author":"Howson","year":"2013","journal-title":"Diabet. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.3933","article-title":"Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases","volume":"21","author":"Li","year":"2015","journal-title":"Nat. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41588-021-00783-5","article-title":"The Polygenic Score Catalog as an open database for reproducibility and systematic evaluation","volume":"53","author":"Lambert","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"D998","DOI":"10.1093\/nar\/gkae1070","article-title":"The NHGRI-EBI GWAS Catalog: Standards for reusability, sustainability and diversity","volume":"53","author":"Cerezo","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ajhg.2021.11.008","article-title":"Portability of 245 polygenic scores when derived from the UK Biobank and applied to 9 ancestry groups from the same cohort","volume":"109","author":"Aschard","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bonifacio, E., Beyerlein, A., Hippich, M., Winkler, C., Vehik, K., Weedon, M.N., Laimighofer, M., Hattersley, A.T., Krumsiek, J., and Frohnert, B.I. (2018). Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: A prospective study in children. PLoS Med., 15.","DOI":"10.1371\/journal.pmed.1002548"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Laine, A.P., Valta, M., Toppari, J., Knip, M., Veijola, R., Ilonen, J., and Lempainen, J. (2022). Non-HLA gene polymorphisms in the pathogenesis of type 1 diabetes: Phase and endotype specific effects. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.909020"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00125-020-05344-9","article-title":"First-appearing islet autoantibodies for type 1 diabetes in young children: Maternal life events during pregnancy and the child\u2019s genetic risk","volume":"64","author":"Johnson","year":"2021","journal-title":"Diabetologia"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Thompson, D.J., Wells, D., Selzam, S., Peneva, I., Moore, R., Sharp, K., Tarran, W.A., Beard, E.J., Riveros-Mckay, F., and Giner-Delgado, C. (2024). A systematic evaluation of the performance and properties of the UK Biobank Polygenic Risk Score (PRS) Release. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0307270"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Perry, D.J., Wasserfall, C.H., Oram, R.A., Williams, M.D., Posgai, A., Muir, A.B., Haller, M.J., Schatz, D.A., Wallet, M.A., and Mathews, C.E. (2018). Application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22574-5"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ajhg.2024.06.003","article-title":"Evaluation of polygenic scoring methods in five biobanks shows larger variation between biobanks than methods and finds benefits of ensemble learning","volume":"111","author":"Monti","year":"2024","journal-title":"Am. J. Hum. Genet."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Raben, T.G., Lello, L., Widen, E., and Hsu, S.D. (2023). Biobank-scale methods and projections for sparse polygenic prediction from machine learning. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-37580-5"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.1038\/s41467-024-48938-2","article-title":"A unified framework for estimating country-specific cumulative incidence for 18 diseases stratified by polygenic risk","volume":"15","author":"Jermy","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1034\/j.1399-5448.2000.010104.x","article-title":"Type 1 diabetes in offspring of parents with type 1 diabetes: The tip of an autoimmune iceberg?","volume":"1","author":"Dorman","year":"2000","journal-title":"Pediatr. Diabetes"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00125-019-4952-8","article-title":"Characteristics of familial type 1 diabetes: Effects of the relationship to the affected family member on phenotype and genotype at diagnosis","volume":"62","author":"Turtinen","year":"2019","journal-title":"Diabetologia"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.2337\/db13-0994","article-title":"Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2\/DR4-DQ8 siblings","volume":"63","author":"Gillespie","year":"2014","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Gokuladhas, S., Schierding, W., Golovina, E., Fadason, T., and O\u2019Sullivan, J. (2021). Unravelling the shared genetic mechanisms underlying 18 autoimmune diseases using a systems approach. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.693142"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1038\/s41467-023-38389-6","article-title":"Cross-disorder genetic analysis of immune diseases reveals distinct gene associations that converge on common pathways","volume":"14","author":"Demela","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/tan.14105","article-title":"High-resolution genotyping indicates that children with type 1 diabetes and celiac disease share three HLA class II loci in DRB3, DRB4 and DRB5 genes","volume":"97","author":"Alshiekh","year":"2021","journal-title":"Hla"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y","article-title":"A soluble form of CTLA-4 generated by alternative splicing is expressed by nonstimulated human T cells","volume":"29","author":"Magistrelli","year":"1999","journal-title":"Eur. J. Immunol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Sirota, M., Schaub, M.A., Batzoglou, S., Robinson, W.H., and Butte, A.J. (2009). Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet., 5.","DOI":"10.1371\/journal.pgen.1000792"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaci.2016.10.055","article-title":"Shared genetic variants suggest common pathways in allergy and autoimmune diseases","volume":"140","author":"Kreiner","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Al Yafei, Z., Mack, S.J., Alvares, M., Ali, B.R., Afandi, B., Beshyah, S.A., Sharma, C., Osman, W., Mirghani, R., and Nasr, A. (2022). HLA-DRB1 and\u2013DQB1 alleles, haplotypes and genotypes in Emirati patients with type 1 diabetes underscores the benefits of evaluating understudied populations. Front. Genet., 13.","DOI":"10.3389\/fgene.2022.841879"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1128\/CVI.00215-08","article-title":"Influence of common and specific HLA-DRB1\/DQB1 haplotypes on genetic susceptibilities of three distinct Arab populations to type 1 diabetes","volume":"16","author":"Stayoussef","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Azulay, R.S.d.S., Porto, L.C., Silva, D.A., Tavares, M.d.G., Reis, R.M.D.F., Nascimento, G.C., Damianse, S.d.S.P., Rocha, V.C.d.C., Magalh\u00e3es, M., and Rodrigues, V. (2021). Genetic ancestry inferred from autosomal and Y chromosome markers and HLA genotypes in Type 1 Diabetes from an admixed Brazilian population. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-93691-x"},{"key":"ref_58","first-page":"324","article-title":"A New Look at the Mechanism of HLA-Associated Predisposition to Type 1 Diabetes Mellitus. Theoretical and Applied Aspects","volume":"26","author":"Boldyreva","year":"2005","journal-title":"Immunologiya"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/1871530319666191119114031","article-title":"Association of HLA-DRB1 and-DQ alleles and haplotypes with type 1 diabetes in Jordanians","volume":"20","author":"Khdair","year":"2020","journal-title":"Endocr. Metab. Immune Disord.-Drug Targets"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1744-313X.2012.01116.x","article-title":"The influence of the HLA-DRB, HLA-DQB and polymorphic positions of the HLA-DR\u03b21 and HLA-DQ\u03b21 molecules on risk of Iranian type 1 diabetes mellitus patients","volume":"39","author":"Sayad","year":"2012","journal-title":"Int. J. Immunogenet."},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Zhao, L.P., Papadopoulos, G.K., Lybrand, T.P., Moustakas, A.K., Bondinas, G.P., Carlsson, A., Larsson, H.E., Ludvigsson, J., Marcus, C., and Persson, M. (2021). The KAG motif of HLA-DRB1 (\u03b271, \u03b274, \u03b286) predicts seroconversion and development of type 1 diabetes. EBioMedicine, 69.","DOI":"10.1016\/j.ebiom.2021.103431"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41467-021-21975-x","article-title":"A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes","volume":"12","author":"Naito","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.humimm.2015.06.012","article-title":"Interleukin-18 promoter-607 C\/A and-137 G\/C polymorphisms and susceptibility to type 1 diabetes: A meta-analysis","volume":"76","author":"Lee","year":"2015","journal-title":"Hum. Immunol."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zhai, N., Bidares, R., Makoui, M.H., Aslani, S., Mohammadi, P., Razi, B., Imani, D., Yazdchi, M., and Mikaeili, H. (2020). Vitamin D receptor gene polymorphisms and the risk of the type 1 diabetes: A meta-regression and updated meta-analysis. BMC Endocr. Disord., 20.","DOI":"10.1186\/s12902-020-00575-8"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/db24-0571","article-title":"Strong Association of Autoantibodies Targeting Deamidated Extracellular Epitopes of Insulinoma Antigen-2 with Clinical Onset of Type 1 Diabetes","volume":"74","author":"Jia","year":"2025","journal-title":"Diabetes"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000543035","article-title":"ISPAD clinical practice consensus guidelines 2024: Screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2025","journal-title":"Horm. Res. Paediatr."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","article-title":"The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening","volume":"63","author":"Jacobsen","year":"2020","journal-title":"Diabetologia"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41467-022-28909-1","article-title":"Progression of type 1 diabetes from latency to symptomatic disease is predicted by distinct autoimmune trajectories","volume":"13","author":"Kwon","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.2337\/dc18-2282","article-title":"Predicting islet cell autoimmunity and type 1 diabetes: An 8-year TEDDY study progress report","volume":"42","author":"Krischer","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Mansachs, S.J., Villumsen, S.O., Johannesen, J., Lind, A., Kaur, S., and Pociot, F. (2022). Genetic variants associated with neuropeptide Y autoantibody levels in newly diagnosed individuals with type 1 diabetes. Genes, 13.","DOI":"10.3390\/genes13050869"},{"key":"ref_71","first-page":"297","article-title":"C-peptide measurement: Methods and clinical utility","volume":"19","author":"Bonser","year":"1984","journal-title":"CRC Crit. Rev. Clin. Lab. Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"e00198","DOI":"10.1002\/edm2.198","article-title":"Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA","volume":"4","author":"Martinez","year":"2021","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Januszewski, A.S., Cho, Y.H., Joglekar, M.V., Farr, R.J., Scott, E.S., Wong, W.K., Carroll, L.M., Loh, Y.W., Benitez-Aguirre, P.Z., and Keech, A.C. (2021). Insulin micro-secretion in Type 1 diabetes and related microRNA profiles. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-90856-6"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Krivova, Y., Proshchina, A., Otlyga, D., Kharlamova, A., and Saveliev, S. (2025). Detection of Insulin in Insulin-Deficient Islets of Patients with Type 1 Diabetes. Life, 15.","DOI":"10.3390\/life15010125"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1530\/EJE-11-0797","article-title":"Levels of C-peptide, body mass index and age, and their usefulness in classification of diabetes in relation to autoimmunity, in adults with newly diagnosed diabetes in Kronoberg, Sweden","volume":"166","author":"Thunander","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-5448.2011.00807.x","article-title":"C-peptide in the classification of diabetes in children and adolescents","volume":"13","author":"Ludvigsson","year":"2012","journal-title":"Pediatr. Diabetes"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2337\/dc10-1293","article-title":"Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-\u03b1\/hepatocyte nuclear factor 4-\u03b1 maturity-onset diabetes of the young from long-duration type 1 diabetes","volume":"34","author":"Besser","year":"2011","journal-title":"Diabetes Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1399-5448.2006.00217.x","article-title":"ISPAD Clinical Practice Consensus Guidelines 2006\u20132007. The diagnosis and management of monogenic diabetes in children","volume":"7","author":"Hattersley","year":"2006","journal-title":"Pediatr. Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"39632","DOI":"10.1074\/jbc.M111.253591","article-title":"Cytokines tumor necrosis factor-\u03b1 and interferon-\u03b3 induce pancreatic \u03b2-cell apoptosis through STAT1-mediated Bim protein activation","volume":"286","author":"Barthson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"15995","DOI":"10.1073\/pnas.0508122102","article-title":"The role of TNF-\u03b1 in the pathogenesis of type 1 diabetes in the nonobese diabetic mouse: Analysis of dendritic cell maturation","volume":"102","author":"Lee","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2018.08.003","article-title":"Interferon alpha: The key trigger of type 1 diabetes","volume":"94","author":"Lombardi","year":"2018","journal-title":"J. Autoimmun."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e1122","DOI":"10.1002\/cti2.1122","article-title":"Cytokines in type 1 diabetes: Mechanisms of action and immunotherapeutic targets","volume":"9","author":"Lu","year":"2020","journal-title":"Clin. Transl. Immunol."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Pan, X., Kaminga, A.C., Kinra, S., Wen, S.W., Liu, H., Tan, X., and Liu, A. (2022). Chemokines in type 1 diabetes mellitus. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.690082"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","article-title":"Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer","volume":"18","author":"Jones","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cyto.2017.01.002","article-title":"Correlation between serum interleukin-6 level and type 1 diabetes mellitus: A systematic review and meta-analysis","volume":"94","author":"Chen","year":"2017","journal-title":"Cytokine"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"eabd6527","DOI":"10.1126\/sciadv.abd6527","article-title":"Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes","volume":"7","author":"Apaolaza","year":"2021","journal-title":"Sci. Adv."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s00125-020-05179-4","article-title":"Innate immune stimulation of whole blood reveals IFN-1 hyper-responsiveness in type 1 diabetes","volume":"63","author":"Rodrigues","year":"2020","journal-title":"Diabetologia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0092-8674(88)90414-X","article-title":"Insulin-dependent diabetes mellitus induced in transgenic mice by ectopic expression of class II MHC and interferon-gamma","volume":"52","author":"Sarvetnick","year":"1988","journal-title":"Cell"},{"key":"ref_89","first-page":"3551","article-title":"IL-17 in pancreatic disease: Pathogenesis and pharmacotherapy","volume":"10","author":"Hu","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nri3823","article-title":"The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases","volume":"15","author":"Klatzmann","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e950547","DOI":"10.4161\/19382014.2014.950547","article-title":"The impact of anti-inflammatory cytokines on the pancreatic \u03b2-cell","volume":"6","author":"Russell","year":"2014","journal-title":"Islets"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-018-4750-8","article-title":"The transcription factor STAT6 plays a critical role in promoting beta cell viability and is depleted in islets of individuals with type 1 diabetes","volume":"62","author":"Leslie","year":"2019","journal-title":"Diabetologia"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/icb.2010.84","article-title":"Interleukin-10 limits the expansion of immunoregulatory CD4- CD8- T cells in autoimmune-prone non-obese diabetic mice","volume":"88","author":"Hillhouse","year":"2010","journal-title":"Immunol. Cell Biol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10875-010-9430-5","article-title":"IL-10\/TGF-\u03b2-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector\/memory T cells from type 1 diabetic individuals","volume":"30","author":"Jara","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1073\/pnas.1304498110","article-title":"Excessive Th1 responses due to the absence of TGF-\u03b2 signaling cause autoimmune diabetes and dysregulated Treg cell homeostasis","volume":"110","author":"Ishigame","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"119014","DOI":"10.1016\/j.lfs.2020.119014","article-title":"Safe and low-dose but therapeutically effective adenovirus-mediated hepatocyte growth factor gene therapy for type 1 diabetes in mice","volume":"268","author":"Matsuda","year":"2021","journal-title":"Life Sci."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.2337\/db24-0159","article-title":"Temporal alterations in CD8+ T cells during the progression from stage 1 to stage 3 type 1 diabetes","volume":"73","author":"Schroderus","year":"2024","journal-title":"Diabetes"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/JLB.3HI0119-024RR","article-title":"Frontline Science: Abnormalities in the gut mucosa of non-obese diabetic mice precede the onset of type 1 diabetes","volume":"106","author":"Miranda","year":"2019","journal-title":"J. Leukoc. Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.2337\/db13-1777","article-title":"A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk for type 1 diabetes","volume":"63","author":"Ferreira","year":"2014","journal-title":"Diabetes"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/dc22-0908","article-title":"Two-year follow-up from the T1GER study: Continued off- therapy metabolic improvements in children and young adults with new-onset T1D treated with golimumab and characterization of responders","volume":"46","author":"Rigby","year":"2023","journal-title":"Diabetes Care"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"03946320231209821","DOI":"10.1177\/03946320231209821","article-title":"Correlation analysis between cytokines\u2019 profile, autoimmune antibodies and the duration of type 1 diabetes: A case control study in a specialized children\u2019s centre in Riyadh","volume":"37","author":"Babiker","year":"2023","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/clinem\/dgac256","article-title":"Expression-based genome-wide association study links OPN and IL1-RA with newly diagnosed type 1 diabetes in children","volume":"107","author":"Jia","year":"2022","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Nigi, L., Brusco, N., Grieco, G.E., Licata, G., Krogvold, L., Marselli, L., Gysemans, C., Overbergh, L., Marchetti, P., and Mathieu, C. (2020). Pancreatic alpha-cells contribute together with beta-cells to CXCL10 expression in type 1 diabetes. Front. Endocrinol., 11.","DOI":"10.3389\/fendo.2020.00630"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Wo\u0142oszyn-Durkiewicz, A., Iwaszkiewicz-Grze\u015b, D., \u015awi\u0119to\u0144, D., Kujawa, M.J., Jankowska, A., Durawa, A., Glasner, P., Tr-zonkowski, P., Glasner, L., and Szurowska, E. (2024). The complex network of cytokines and chemokines in pediatric patients with long-standing type 1 diabetes. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25031565"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e70270","DOI":"10.1096\/fj.202402354R","article-title":"Sex-specific cytokine, chemokine, and growth factor signatures in T1D patients and progressors","volume":"38","author":"Girdhar","year":"2024","journal-title":"FASEB J."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cyto.2016.07.007","article-title":"Increased serum levels of novel T cell cytokines IL-33, IL-9 and IL-17 in subjects with type-1 diabetes","volume":"86","author":"Shruthi","year":"2016","journal-title":"Cytokine"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.4049\/jimmunol.173.11.6603","article-title":"Early and quantal (by litter) expression of insulin autoantibodies in the nonobese diabetic mice predict early diabetes onset","volume":"173","author":"Melanitou","year":"2004","journal-title":"J. Immunol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"144785","DOI":"10.1016\/j.gene.2020.144785","article-title":"Investigation of type 1 diabetes in NOD mice knockout for the osteopontin gene","volume":"753","author":"Melanitou","year":"2020","journal-title":"Gene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1007\/s40618-016-0514-9","article-title":"Association between type 1, type 2 cytokines, diabetic autoantibodies and 25-hydroxyvitamin D in children with type 1 diabetes","volume":"39","author":"Talaat","year":"2016","journal-title":"J. Endocrinol. Investig."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"117151","DOI":"10.1016\/j.atherosclerosis.2023.05.020","article-title":"Sustained low-grade inflammation in young participants with childhood onset type 1 diabetes: The Norwegian atherosclerosis and childhood diabetes (ACD) study","volume":"379","author":"Simeunovic","year":"2023","journal-title":"Atherosclerosis"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1464-5491.2007.02096.x","article-title":"Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission","volume":"24","author":"Schloot","year":"2007","journal-title":"Diabet. Med."},{"key":"ref_113","doi-asserted-by":"crossref","unstructured":"Gomez-Mu\u00f1oz, L., Perna-Barrull, D., Caroz-Armayones, J.M., Murillo, M., Rodriguez-Fernandez, S., Valls, A., Vazquez, F., Perez, J., Corripio, R., and Casta\u00f1o, L. (2022). Candidate biomarkers for the prediction and monitoring of partial remission in pediatric type 1 diabetes. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.825426"},{"key":"ref_114","doi-asserted-by":"crossref","unstructured":"Krishnamurthy, B., Lacorcia, M., Kay, T.W., Thomas, H.E., and Mannering, S.I. (2023). Monitoring immunomodulation strategies in type 1 diabetes. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1206874"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1073\/pnas.1700878114","article-title":"Progression of type 1 diabetes from the prediabetic stage is controlled by interferon-\u03b1 signaling","volume":"114","author":"Marro","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.cca.2011.01.026","article-title":"Origin, translocation and destination of extracellular occurring DNA\u2014A new paradigm in genetic behaviour","volume":"412","author":"Peters","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI105479","article-title":"Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus","volume":"45","author":"Tan","year":"1966","journal-title":"J. Clin. Investig."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Stawski, R., Walczak, K., Kosielski, P., Meissner, P., Budlewski, T., Padula, G., and Nowak, D. (2017). Repeated bouts of exhaustive exercise increase circulating cell free nuclear and mitochondrial DNA without development of tolerance in healthy men. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0178216"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7186137","DOI":"10.1155\/2016\/7186137","article-title":"Plasma cytokine profiles in long-term strenuous exercise","volume":"2016","author":"Nielsen","year":"2016","journal-title":"J. Sports Med."},{"key":"ref_120","first-page":"6","article-title":"Systemic inflammatory response to exhaustive exercise. Cytokine kinetics","volume":"8","author":"Suzuki","year":"2002","journal-title":"Exerc. Immunol. Rev."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"6","DOI":"10.30629\/2618-6667-2021-19-3-6-14","article-title":"Concentration of circulating cell-free DNA in the peripheral blood plasma of patients with acute endogenous and exogenous etiology psychoses","volume":"19","author":"Jestkova","year":"2021","journal-title":"Psikhiatriya"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"19018","DOI":"10.1073\/pnas.1111008108","article-title":"Detection of \u03b2 cell death in diabetes using differentially methylated circulating DNA","volume":"108","author":"Akirav","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2337\/db12-1207","article-title":"Immune therapy and \u03b2-cell death in type 1 diabetes","volume":"62","author":"Lebastchi","year":"2013","journal-title":"Diabetes"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.molmet.2019.06.013","article-title":"\u03b2 cell responses to inflammation","volume":"27","author":"Perdigoto","year":"2019","journal-title":"Mol. Metab."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1210\/en.2013-1223","article-title":"Detection of islet \u03b2-cell death in vivo by multiplex PCR analysis of differentially methylated DNA","volume":"154","author":"Fisher","year":"2013","journal-title":"Endocrinology"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Husseiny, M.I., Kuroda, A., Kaye, A.N., Nair, I., Kandeel, F., and Ferreri, K. (2012). Development of a quantitative methylation-specific polymerase chain reaction method for monitoring beta cell death in type 1 diabetes. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047942"},{"key":"ref_127","doi-asserted-by":"crossref","unstructured":"Walczak, K., Stawski, R., Perdas, E., Brzezinska, O., Kosielski, P., Galczynski, S., Budlewski, T., Padula, G., and Nowak, D. (2021). Circulating cell free DNA response to exhaustive exercise in average trained men with type I diabetes mellitus. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-84201-0"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.2337\/db14-0480","article-title":"Increased neutrophil elastase and proteinase 3 and augmented NETosis are closely associated with \u03b2-cell autoimmunity in patients with type 1 diabetes","volume":"63","author":"Wang","year":"2014","journal-title":"Diabetes"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/TP.0000000000002083","article-title":"Beta cell death by cell-free DNA and outcome after clinical islet transplantation","volume":"102","author":"Neiman","year":"2018","journal-title":"Transplantation"},{"key":"ref_130","first-page":"E1826","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Neiman","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13148-020-00906-5","article-title":"Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes","volume":"12","author":"Syed","year":"2020","journal-title":"Clin. Epigenet."},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Husseiny, M.I., Kaye, A., Zebadua, E., Kandeel, F., and Ferreri, K. (2014). Tissue-specific methylation of human insulin gene and PCR assay for monitoring beta cell death. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094591"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Gezer, U., \u00d6zg\u00fcr, E., Y\u00f6r\u00fcker, E.E., Polatoglou, E., Holdenrieder, S., and Bronkhorst, A. (2024). LINE-1 cfDNA methylation as an emerging biomarker in solid cancers. Cancers, 16.","DOI":"10.3390\/cancers16223725"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Kurdyukov, S., and Bullock, M. (2016). DNA methylation analysis: Choosing the right method. Biology, 5.","DOI":"10.3390\/biology5010003"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Tabakov, D.V., Maznina, A.A., Astakhova, E.A., Egorova, A.E., Zakharova, E.N., Glushkova, O.V., Petriaikina, E.S., Svetlichnyy, D., Krupinova, J.A., and Bogdanov, V.P. (2025). Diagnosis of cancer, autoimmune and infectious diseases and prediction of the therapy effectiveness based on the individual\u2019s immunotype. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1658970"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13098-023-01096-9","article-title":"Higher \u03b2 cell death in pregnant women, measured by DNA methylation patterns of cell-free DNA, compared to new-onset type 1 and type 2 diabetes subjects: A cross-sectional study","volume":"15","author":"Rubio","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"e136579","DOI":"10.1172\/jci.insight.136579","article-title":"Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic \u03b2 cells","volume":"5","author":"Neiman","year":"2020","journal-title":"JCI Insight"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","article-title":"Biomarkers of islet beta cell stress and death in type 1 diabetes","volume":"61","author":"Sims","year":"2018","journal-title":"Diabetologia"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.tibs.2021.01.007","article-title":"Extracellular miRNAs and cell-cell communication: Problems and prospects","volume":"46","author":"Makarova","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","unstructured":"Angelescu, M.A., Andronic, O., Dima, S.O., Popescu, I., Meivar-Levy, I., Ferber, S., and Lixandru, D. (2022). miRNAs as biomarkers in diabetes: Moving towards precision medicine. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232112843"},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Krishnan, P., Branco, R.C.S., Weaver, S.A., Chang, G., Lee, C.C., Syed, F., and Evans-Molina, C. (2024). miR-146a-5p mediates inflammation- induced \u03b2 cell mitochondrial dysfunction and apoptosis. J. Biol. Chem., 300.","DOI":"10.1101\/2024.03.18.585543"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s00125-017-4237-z","article-title":"MicroRNA 21 targets BCL2 mRNA to increase apoptosis in rat and human beta cells","volume":"60","author":"Sims","year":"2017","journal-title":"Diabetologia"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"36275","DOI":"10.1074\/jbc.M114.592360","article-title":"MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis","volume":"289","author":"Filios","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Yoshihara, E. (2020). TXNIP\/TBP-2: A master regulator for glucose homeostasis. Antioxidants, 9.","DOI":"10.3390\/antiox9080765"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s00125-019-05026-1","article-title":"miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes","volume":"63","author":"Ventriglia","year":"2020","journal-title":"Diabetologia"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.lfs.2014.10.001","article-title":"Reprint of: MiRNA-1 regulates endothelin-1 in diabetes","volume":"118","author":"Feng","year":"2014","journal-title":"Life Sci."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"2734490","DOI":"10.1155\/2022\/2734490","article-title":"Progression of type 1 diabetes: Circulating microRNA expression profiles changes from preclinical to overt disease","volume":"2022","author":"Santos","year":"2022","journal-title":"J. Immunol. Res."},{"key":"ref_148","doi-asserted-by":"crossref","unstructured":"Taheri, M., Eghtedarian, R., Dinger, M.E., and Ghafouri-Fard, S. (2020). Emerging roles of non-coding RNAs in the pathogenesis of type 1 diabetes mellitus. Biomed. Pharmacother., 129.","DOI":"10.1016\/j.biopha.2020.110509"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1007\/s00125-020-05237-x","article-title":"Plasma circulating miR-23\u02dc 27\u02dc 24 clusters correlate with the immunometabolic derangement and predict C-peptide loss in children with type 1 diabetes","volume":"63","author":"Garavelli","year":"2020","journal-title":"Diabetologia"},{"key":"ref_150","doi-asserted-by":"crossref","unstructured":"Fr\u00f8rup, C., Mirza, A.H., Yarani, R., Nielsen, L.B., Mathiesen, E.R., Damm, P., Svare, J., Engelbrekt, C., St\u00f8rling, J., and Johannesen, J. (2021). Plasma exosome-enriched extracellular vesicles from lactating mothers with type 1 diabetes contain aberrant levels of miRNAs during the postpartum period. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.744509"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Mirza, A.H., Kaur, S., Nielsen, L.B., St\u00f8rling, J., Yarani, R., Roursgaard, M., Mathiesen, E.R., Damm, P., Svare, J., and Mortensen, H.B. (2019). Breast milk-derived extracellular vesicles enriched in exosomes from mothers with type 1 diabetes contain aberrant levels of microRNAs. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02543"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2392343","DOI":"10.1080\/19382014.2024.2392343","article-title":"Small RNA-Seq and real time rt-qPCR reveal islet miRNA released under stress conditions","volume":"16","author":"Aljani","year":"2024","journal-title":"Islets"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1373\/clinchem.2010.147405","article-title":"The microRNA spectrum in 12 body fluids","volume":"56","author":"Weber","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"413","DOI":"10.20514\/2226-6704-2023-13-6-413-421","article-title":"Relationship of MicroRNAs with Transposable Elements in the Type 1 Diabetes Development","volume":"13","author":"Mustafin","year":"2024","journal-title":"Russ. Arch. Intern. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"E1661","DOI":"10.1210\/jc.2013-3868","article-title":"Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: A cross-sectional cohort study","volume":"99","author":"Osipova","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_156","unstructured":"(2025). Blood collection tube and RNA purification method recommendations for extracellular RNA transcriptome profiling. Nat. Commun., 16, 4513."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Swolin-Eide, D., Forsander, G., Pundziute Lyck\u00e5, A., Novak, D., Grillari, J., Diendorfer, A.B., Hackl, M., and Magnusson, P. (2023). Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-38615-7"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Nizam, R., Malik, M.Z., Jacob, S., Alsmadi, O., Koistinen, H.A., Tuomilehto, J., Alkandari, H., Al-Mulla, F., and Thanaraj, T.A. (2024). Circulating hsa-miR-320a and its regulatory network in type 1 diabetes mellitus. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1376416"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41586-018-0836-1","article-title":"Genomic encoding of transcriptional burst kinetics","volume":"565","author":"Larsson","year":"2019","journal-title":"Nature"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00125-022-05699-1","article-title":"Lessons from single-cell RNA sequencing of human islets","volume":"65","author":"Ngara","year":"2022","journal-title":"Diabetologia"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1038\/s41573-023-00688-4","article-title":"Applications of single-cell RNA sequencing in drug discovery and development","volume":"22","author":"Lee","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"Pu, Z., Chen, S., Lu, Y., Wu, Z., Cai, Z., and Mou, L. (2024). Exploring the molecular mechanisms of macrophages in islet transplantation using single-cell analysis. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1407118"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.40793","article-title":"Association of Dendritic cell signatures with autoimmune inflammation revealed by Single-Cell profiling","volume":"71","author":"Ashton","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/s42255-022-00531-x","article-title":"Single-cell multi-omics analysis of human pancreatic islets reveals novel cellular states in type 1 diabetes","volume":"4","author":"Fasolino","year":"2022","journal-title":"Nat. Metab."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"106588","DOI":"10.1016\/j.phrs.2022.106588","article-title":"Single-cell RNA sequencing highlights the roles of C1QB and NKG7 in the pancreatic islet immune microenviron- ment in type 1 diabetes mellitus","volume":"187","author":"Ji","year":"2023","journal-title":"Pharmacol. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Nakayama, M., and Michels, A.W. (2021). Using the T cell receptor as a biomarker in type 1 diabetes. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.777788"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"e161885","DOI":"10.1172\/jci.insight.161885","article-title":"Temporal development of T cell receptor repertoires during childhood in health and disease","volume":"7","author":"Mitchell","year":"2022","journal-title":"JCI Insight"},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Pogorelyy, M.V., Kirk, A.M., Adhikari, S., Minervina, A.A., Sundararaman, B., Vegesana, K., Brice, D.C., Scott, Z.B., Thomas, P.G., and Team, S.S. (2024). TIRTL-seq: Deep, quantitative, and affordable paired TCR repertoire sequencing. bioRxiv.","DOI":"10.1101\/2024.09.16.613345"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00125-024-06298-y","article-title":"The Type 1 Diabetes T Cell Receptor and B Cell Receptor Repository in the AIRR Data Commons: A practical guide for access, use and contributions through the Type 1 Diabetes AIRR Consortium","volume":"68","author":"Hanna","year":"2025","journal-title":"Diabetologia"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"103036","DOI":"10.1016\/j.pdpdt.2022.103036","article-title":"FTIR spectroscopy as a point of care diagnostic tool for diabetes and periodontitis: A saliva analysis approach","volume":"40","author":"Nogueira","year":"2022","journal-title":"Photodiagn. Photodyn. Ther."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Kondrakhova, D., Unger, M., Stadler, H., Zakut\u2019ansk\u00e1, K., Toma\u0161ovic\u02c7ov\u00e1, N., Tomec\u02c7kov\u00e1, V., Hor\u00e1k, J., Kim\u00e1kova, T., and Komanicky, V. (2025). Determination diabetes mellitus disease markers in tear fluid by photothermal AFM-IR analysis. Nanomed. Nanotechnol. Biol. Med., 64.","DOI":"10.1016\/j.nano.2025.102803"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1039\/D3AN01519J","article-title":"Serum-based ATR-FTIR spectroscopy combined with multivariate analysis for the diagnosis of pre-diabetes and diabetes","volume":"149","author":"Pang","year":"2024","journal-title":"Analyst"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"4926","DOI":"10.1039\/D3AY01080E","article-title":"Prediction of type 1 diabetes with machine learning algorithms based on FTIR spectral data in peripheral blood mononuclear cells","volume":"15","author":"Rostoka","year":"2023","journal-title":"Anal. Methods"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Synytsya, A., Janstova, D., \u0160midov\u00e1, M., Synytsya, A., and Petrt\u00fdl, J. (2023). Evaluation of IR and Raman spectroscopic markers of human collagens: Insides for indicating colorectal carcinogenesis. Spectrochim. Acta Part A Mol. Biomol. Spectrosc., 296.","DOI":"10.1016\/j.saa.2023.122664"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.artmed.2019.07.007","article-title":"Data-driven modeling and prediction of blood glucose dynamics: Machine learning applications in type 1 diabetes","volume":"98","author":"Woldaregay","year":"2019","journal-title":"Artif. Intell. Med."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijleo.2018.11.059","article-title":"Pre-diabetes diagnosis based on ATR-FTIR spectroscopy combined with CART and XGBoots","volume":"180","author":"Yang","year":"2019","journal-title":"Optik"},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Wu, X., Shuai, W., Chen, C., Chen, X., Luo, C., Chen, Y., Shi, Y., Li, Z., Lv, X., and Chen, C. (2023). Rapid screening for autoimmune diseases using Fourier transform infrared spectroscopy and deep learning algorithms. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1328228"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"American Diabetes Association Professional Practice Committee (2025). 2. Diagnosis and classification of diabetes: Standards of care in diabetes\u20142025. Diabetes Care, 48, S27\u2013S49.","DOI":"10.2337\/dc25-S002"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: A status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"ref_180","unstructured":"(2025, May 12). INNODIA. Available online: https:\/\/www.innodia.eu\/."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"e167881","DOI":"10.1172\/jci.insight.167881","article-title":"Islet-autoreactive CD4+ T cells are linked with response to alefacept in type 1 diabetes","volume":"8","author":"Balmas","year":"2023","journal-title":"JCI Insight"},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"93\u2013OR","DOI":"10.2337\/db24-93-OR","article-title":"93-OR: Clonal Expansion of Islet Reactive CD4 T-Cells with Early Disease Progression in Type 1 Diabetes","volume":"73","author":"Edwards","year":"2024","journal-title":"Diabetes"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Speake, C., Bahnson, H.T., Wesley, J.D., Perdue, N., Friedrich, D., Pham, M.N., Lanxon-Cookson, E., Kwok, W.W., Sehested Hansen, B., and von Herrath, M. (2019). Systematic assessment of immune marker variation in type 1 diabetes: A prospective longitudinal study. Front. Immunol., 10.","DOI":"10.3389\/fimmu.2019.02023"},{"key":"ref_184","doi-asserted-by":"crossref","unstructured":"Abdullatypov, A.V., Glushkova, O.V., Petriaikina, E.S., Bogdanov, V.P., Antysheva, Z.G., Tabakov, D.V., Akimov, V.E., Yudin, V.S., Keskinov, A.A., and Yudin, S.M. (2025). Single-cell RNA sequencing (scRNA-seq) in studies of type 1 diabetes mellitus (T1D): Modern state-of-the-art and technical peculiarities. Front. Endocrinol., 16.","DOI":"10.3389\/fendo.2025.1663728"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2444\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T04:34:18Z","timestamp":1760157258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":184,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biomedicines13102444"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13102444","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]}}}